Skip to Main content Skip to Navigation
Journal articles

Efflux Pump Blockers in Gram-Negative Bacteria: The New Generation of Hydantoin Based-Modulators to Improve Antibiotic Activity

Abstract : Multidrug resistant (MDR) bacteria are an increasing health problem with the shortage of new active antibiotic agents. Among effective mechanisms that contribute to the spread of MDR Gram-negative bacteria are drug efflux pumps that expel clinically important antibiotic classes out of the cell. Drug pumps are attractive targets to restore the susceptibility toward the expelled antibiotics by impairing their efflux activity. Arylhydantoin derivatives were investigated for their potentiation of activities of selected antibiotics described as efflux substrates in Enterobacter aerogenes expressing or not AcrAB pump. Several compounds increased the bacterial susceptibility toward nalidixic acid, chloramphenicol and sparfloxacin and were further pharmacomodulated to obtain a better activity against the AcrAB producing bacteria.
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-01463003
Contributor : Jean-Marie Pages <>
Submitted on : Thursday, February 16, 2017 - 4:39:10 PM
Last modification on : Thursday, September 6, 2018 - 4:36:04 PM
Long-term archiving on: : Wednesday, May 17, 2017 - 12:11:17 PM

File

fmicb-2016.pdf
Explicit agreement for this submission

Identifiers

Collections

Citation

Ewa Otrebska-Machaj, Jacqueline Chevalier, Jadwiga Handzlik, Ewa Szymánska, Jakub Schabikowski, et al.. Efflux Pump Blockers in Gram-Negative Bacteria: The New Generation of Hydantoin Based-Modulators to Improve Antibiotic Activity. Frontiers in Microbiology, Frontiers Media, 2016, 7, pp.622. ⟨10.3389/fmicb.2016.00622⟩. ⟨hal-01463003⟩

Share

Metrics

Record views

123

Files downloads

231